NCT06218459

Brief Summary

The goal is to undertake a Decentralized Randomized Pilot Feasibility study to inform the methods for a definitive Randomized Controlled Trial (RCT) (including recruitment success, participant experience, intervention delivery, safety, outcome measurement and sample size estimation). The main question is if the methods used are feasible for an adequately powered future RCT. Participants will be randomly allocated to receive either: Intervention - OldPain2Go® treatment or Placebo Control - Jacobson's progressive relaxation

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable low-back-pain

Timeline
Completed

Started May 2024

Typical duration for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 23, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2025

Completed
Last Updated

September 8, 2025

Status Verified

September 1, 2025

Enrollment Period

1.3 years

First QC Date

January 10, 2024

Last Update Submit

September 2, 2025

Conditions

Keywords

Chronic PainFeasibility Study

Outcome Measures

Primary Outcomes (2)

  • 0-10 Numeric Rating Scale for Pain Intensity

    A standard measure in most pain studies. Participants are asked to rate their pain on a 0-10 scale with 0 being no pain and 10 being worst imaginable pain. A higher score means greater pain. An increase in score, over time, means an increase in pain and a worse outcome.

    Change measures at six time points, baseline, immediately after treatment, 1 week and 2, 4 and 12 weeks from baseline.

  • The Roland Morris Disability Questionnaire

    A standard measure used in most low back pain studies to measure the degree of a person's disability. It is a 24 item, closed question, self-completed questionnaire. Each item is scored as zero or one and the minimum score is zero and maximum is 24. A higher score means greater self-rated physical disability caused by low back pain. An increase in score, over time, means an increase in self-rated physical disability caused by low back pain and a worse outcome.

    Change measures at five time points, baseline, 1 week and 2, 4 and 12 weeks from baseline

Study Arms (2)

Oldpain2go®

EXPERIMENTAL

This is a concept of dealing with a client in a way that uses their conscious mind to alter their unconscious automated programs (chronic pain) that are troubling them.

Other: Oldpain2go®

Jacobson's progressive relaxation

PLACEBO COMPARATOR

Jacobson's progressive relaxation is used in a range of conditions to relieve muscle tension and stress as part of self-management.

Other: Jacobson's progressive relaxation

Interventions

OldPain2Go® is a non-medical intervention for the treatment of chronic pain conditions including, but not limited to Chronic Low Back Pain. The underlying premise is rooted in the biopsychosocial model of pain, where the cause of ongoing pain and the development of chronicity, is believed to lie beyond simple tissue damage, injury or malfunction. The intervention draws upon subconscious communication as a means to help patients to re-frame their pain as less threatening and remove old, out of date, pain messages that no longer serve a purpose.

Oldpain2go®

Jacobson's progressive relaxation is a technique commonly used for eliciting the relaxation response and relieving muscular tension. It involves sequentially relaxing various muscle groups, often starting at the head and moving down the body to the feet.

Jacobson's progressive relaxation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Currently suffering from persistent, non-specific, low back pain of six or more months duration
  • No known tissue damage, structural abnormality, or pathology causing persistent low back pain
  • Aged over 18 years
  • Person's for whom Oldpain2go® is indicated as a treatment option, after the standard clinical screening process for the Oldpain2go® treatment
  • Has access to digital communication device able to host encrypted secure on-line meetings.

You may not qualify if:

  • Any Red Flags,
  • Any causative (or potentially causative) structural abnormality, or pathology detected or suspected
  • Any concurrent pathology, or condition that would render them unsuitable for on-line virtual assessment and Physiotherapy treatment
  • Lack of (or any reason to doubt presence of) Mental Capacity to give Informed Consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Norton Physiotherapy Centre

Norton, Stockton-on-Tees, TS20 2PT, United Kingdom

Location

MeSH Terms

Conditions

Low Back PainChronic Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Alasdair MacSween, PhD

    Teesside University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Double blind
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: Sequential randomised assignment to intervention or control arms.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Lecturer (Research and Innovation)

Study Record Dates

First Submitted

January 10, 2024

First Posted

January 23, 2024

Study Start

May 1, 2024

Primary Completion

August 31, 2025

Study Completion

August 31, 2025

Last Updated

September 8, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

The non-person identifiable data set (non-person identifiable demographics and outcome measure data) will be available on as an Excel Spreadsheet on Teesside University's Mendeley Data account and will be accessible to all under Attribution 4.0 International (CC BY 4.0) licence.

Shared Documents
STUDY PROTOCOL, ANALYTIC CODE
Time Frame
The non-person identifiable data set will be made available when analysis has been completed and written up for submission as a scientific journal article and will remain available indefinitely
Access Criteria
The data will be owned by Teesside University and no restrictions will be placed on the use or access to the non-person identifiable data set available on Mendeley Data other than those restrictions included in Attribution 4.0 International (CC BY 4.0) licence.

Locations